Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linnea is a Swiss-based manufacturer specializing in the production of high-quality botanical extracts and natural active pharmaceutical ingredients (APIs) for the pharmaceutical, nutraceutical, and cosmetic industries. Founded in 1982 as a joint venture between the Schwabe Group and Indena, the company operates a state-of-the-art GMP-certified facility in Riazzino. Linnea's product portfolio includes standardized extracts such as Ginkgo biloba, Bilberry, and a comprehensive range of cannabinoids including CBD and CBG. The company provides end-to-end services from raw material sourcing and extraction to purification and final product formulation. Linnea is recognized globally for its commitment to Swiss quality standards, rigorous analytical testing, and sustainable manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linnea Natural Pharma Solutions.